Dianthus Therapeutics, Inc.
(DNTH - NASDAQ)
87,13 USD
📋 Profilo Aziendale

Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases.

|